Mohamed Shehata Draz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohamed Shehata Draz has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Bingxiang Liu
College of Forestry, Agricultural University of Hebei, Baoding, 071001, China
1 shared publication- Hadi Shafiee
Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
1 shared publication - Pengfei Zhang
Department of Central Laboratory, Shanghai Skin Disease Hospital, School of Medicine
1 shared publication Xianghong Wang
College of Food Science and Technology, Agricultural University of Hebei, Baoding, 071001, china
1 shared publicationXiuying Liu
College of Food Science & Project Engineering, Bohai University, Jinzhou, 121013, China
1 shared publication- Xue Gao
College of Food Science and Technology, Bohai University, National & Local Joint Engineering Research Center of Storage, Processing and Safety Control Technology for Fresh Agricultural and Aquatic Products, Food Safety Key Lab of Liaoning Province, Institute of Ocean Research, The Fresh Food Storage and Processing Technology Research Institute of Liaoning Provincial Universities, Jinzhou, Liaoning 121013, China
1 shared publication
Latest Publications
- 7 May 2019
- Published by Springer Nature in Microchimica Acta
- Vol. 186 (6) , 334
Fluorometric determination of ciprofloxacin using molecularly imprinted polymer and polystyrene microparticles doped with europium(III)(DBM)3phen
The authors describe a microparticle-based system for the detection of the fluoroquinolone antibiotic ciprofloxacin. The method is using the tris(dibenzoylmethane)(1,10-phenanthroline)europium(III) luminophore in polystyrene microparticles along with a molecularly imprinted polymer (MIP) for ciprofloxacin. If ciprofloxacin is captured by the MIP, it quenches the fluorescence of the luminophores. Fluorescence drops linearly in the 0.5–100 μg L−1 ciprofloxacin concentration range, and the detection limit is 92 ng L−1. The method was applied to the analysis of fish samples to assess the analytical performance of the probe. Recoveries ranged from 85.4 to 86.6%, and relative standard deviations between 2.1 and 3.9% (for n = 5).
- 7 May 2019
- Published by Springer Nature in Microchimica Acta
- Vol. 186 (6) , 334
Fluorometric determination of ciprofloxacin using molecularly imprinted polymer and polystyrene microparticles doped with europium(III)(DBM)3phen
The authors describe a microparticle-based system for the detection of the fluoroquinolone antibiotic ciprofloxacin. The method is using the tris(dibenzoylmethane)(1,10-phenanthroline)europium(III) luminophore in polystyrene microparticles along with a molecularly imprinted polymer (MIP) for ciprofloxacin. If ciprofloxacin is captured by the MIP, it quenches the fluorescence of the luminophores. Fluorescence drops linearly in the 0.5–100 μg L−1 ciprofloxacin concentration range, and the detection limit is 92 ng L−1. The method was applied to the analysis of fish samples to assess the analytical performance of the probe. Recoveries ranged from 85.4 to 86.6%, and relative standard deviations between 2.1 and 3.9% (for n = 5).
- Open Access
- 11 April 2019
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 19 (4) , 243
Advanced Theranostic Application of Bio-Nanoparticle Systems
- 11 April 2019
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 19 (4) , 243
Open AccessAdvanced Theranostic Application of Bio-Nanoparticle Systems
- Top Cited PapersOpen Access
- 1 January 2018
- Published by Ivyspring International Publisher in Theranostics
- Vol. 8 (7) , 1985-2017
Applications of gold nanoparticles in virus detection
Viruses are the smallest known microbes, yet they cause the most significant losses in human health. Most of the time, the best-known cure for viruses is the innate immunological defense system of the host; otherwise, the initial prevention of viral infection is the only alternative. Therefore, diagnosis is the primary strategy toward the overarching goal of virus control and elimination. The introduction of a new class of nanoscale materials with multiple unique properties and functions has sparked a series of breakthrough applications. Gold nanoparticles (AuNPs) are widely reported to guide an impressive resurgence in biomedical and diagnostic applications. Here, we review the applications of AuNPs in virus testing and detection. The developed AuNP-based detection techniques are reported for various groups of clinically relevant viruses with a special focus on the applied types of bio-AuNP hybrid structures, virus detection targets, and assay modalities and formats. We pay particular attention to highlighting the functional role and activity of each core Au nanostructure and the resultant detection improvements in terms of sensitivity, detection range, and time. In addition, we provide a general summary of the contributions of AuNPs to the mainstream methods of virus detection, technical measures, and recommendations required in guidance toward commercial in-field applications.
- 1 January 2018
- Published by Ivyspring International Publisher in Theranostics
- Vol. 8 (7) , 1985-2017
Top Cited PapersOpen AccessApplications of gold nanoparticles in virus detection
Viruses are the smallest known microbes, yet they cause the most significant losses in human health. Most of the time, the best-known cure for viruses is the innate immunological defense system of the host; otherwise, the initial prevention of viral infection is the only alternative. Therefore, diagnosis is the primary strategy toward the overarching goal of virus control and elimination. The introduction of a new class of nanoscale materials with multiple unique properties and functions has sparked a series of breakthrough applications. Gold nanoparticles (AuNPs) are widely reported to guide an impressive resurgence in biomedical and diagnostic applications. Here, we review the applications of AuNPs in virus testing and detection. The developed AuNP-based detection techniques are reported for various groups of clinically relevant viruses with a special focus on the applied types of bio-AuNP hybrid structures, virus detection targets, and assay modalities and formats. We pay particular attention to highlighting the functional role and activity of each core Au nanostructure and the resultant detection improvements in terms of sensitivity, detection range, and time. In addition, we provide a general summary of the contributions of AuNPs to the mainstream methods of virus detection, technical measures, and recommendations required in guidance toward commercial in-field applications.